白血病/淋巴瘤免疫分型检测质量控制指南

doi:10.3969/j.issn.1673-8640.2019.04.001

摘要/Abstract

中图分类号:

R446.1

中国免疫学会血液免疫分会临床流式细胞术学组. 白血病/淋巴瘤免疫分型检测质量控制指南[J]. 检验医学, 2019, 34(4): 285-299.

图/表 1

参考文献 22

[1]	Clinical and Laboratory Standards Institute. Clinical flow cytometric analysis of neoplastic hematolymphoid cells[S]. H43-A2,CLSI,2007.
[2]	JOHANSSON U,BLOXHAM D,COUZENS S,et al.Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology[J]. Br J Haematol,2014,165(4):455-488.
[3]	DAVIS B H,DASGUPTA A,KUSSICK S,et al.Validation of cell-based fluorescence assays:practice guidelines from the ICSH and ICCS-part Ⅱ-preanalytical issues[J]. Cytometry B Clin Cytom,2013,84(5):286-290.
[4]	TANQRI S,VALL H,KAPLAN D,et al.Validation of cell-based fluorescence assays:practice guidelines from the ICSH and ICCS-part Ⅲ-analytical issues[J]. Cytometry B Clin Cytom,2013,84(5):291-308.
[5]	BARNETT D,LOUZAO R,GAMBELL P,et al.Validation of cell-based fluorescence assays:practice guidelines from the ICSH and ICCS-part Ⅳ-postanalytic considerations[J]. Cytometry B Clin Cytom,2013,84(5):309-314.
[6]	WOOD B.9-Color and 10-color flow cytometry in the clinical laboratory[J]. Arch Pathol Lab Med,2006,130(5):680-690.
[7]	中华医学会检验医学分会,卫生部临床检验中心,中华检验医学杂志编辑委员会. 流式细胞术临床应用的建议[J]. 中华检验医学杂志,2013,36(12):1064-1073.
[8]	ELGHETANY M T,DAVIS B H.Impact of preanalytical variables on granulocytic surface antigen expression:a review[J]. Cytometry B Clin Cytom,2005,65(1):1-5.
[9]	KAPPELMAYER J.Flow cytometric detection of intracellular myeloperoxidase,cd3 and cd79a. Interaction between monoclonal antibody clones,fluorochromes and sample preparation protocols[J]. J Immun Method,2000,242(1):53-65.
[10]	PLEBANI M.Errors in clinical laboratories or errors in laboratory medicine?[J]. Clin Chem Lab Med,2006,44(6):750-759.
[11]	JOHANSSON U,BLOXHAM D,COUZENS S,et al.Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology[J]. Br J Haematol,2014,165(4):455-488.
[12]	MEINELT E,REUNANEN M,EDINGER M,et al.Standardizing application setup across multiple flow cytometers using BD FACSDivaTM version 6 software[Z]. 2012.
[13]	NOMURA L,MAINO V C,MAECKER H T.Standardization and optimization of multiparameter intracellular cytokine staining[J]. Cytometry A,2008,73(11):984-991.
[14]	MAECKER H T,TROTTER J.Flow cytometry controls,instrument setup,and the determination of positivity[J]. Cytometry A,2006,69(9):1037-1042.
[15]	MAHNKE Y D,ROEDERER M.Optimizing a multicolor immunophenotyping assay[J]. Clin Lab Med,2007,27(3):469-485.
[16]	JOHANSSON U,MACEY M.Tandem dyes:stability in cocktails and compensation considerations[J]. Cytometry B Clin Cytom,2014,86(3):164-174.
[17]	DIGIUSEPPE J A,CARDINALI J.Improved compensation of the fluorochrome AmCyan using cellular controls[J]. Cytometry B Clin Cytom,2011,80(3):191-194.
[18]	RATEI R,KARAWAJEW L,LACOMBE F,et al.Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias[J]. Cytometry B Clin Cytom,2006,70(1):1-9.
[19]	BOROWITZ M J,BRAY R,GASCOYNE R,et al.U. S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry:data analysis and interpretation[J]. Cytometry,1997,30(5):236-244.
[20]	PÉREZ-ANDRÉS M,SANTIAGO M,ALMEIDA J,et al. Immunophenotypic approach to the identification and characterization of clonal plasma cells from patients with monoclonal gammopathies[J]. J Biol Regul Homeost Agents,2004,18(3-4):392-398.
[21]	Clinical and Laboratory Standards Institute. Fluorescence calibration and quantitative measurement of fluorescence intensity[S]. I/LA24,CLSI,2004.
[22]	CRAIG F E,FOON K A.Flow cytometric immunophenotyping for hematologic neoplasms[J]. Blood,2008,111(8):3941-3967.

白血病/淋巴瘤免疫分型检测质量控制指南

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 22

相关文章 15

编辑推荐

Metrics

[1]	范列英. 膜性肾病生物标志物的研究现状与应用展望[J]. 检验医学, 2023, 38(12): 1111-1114.
[2]	孙林成, 李建锋, 程维丽, 姬攀云. 抗PLA2R IgG4抗体、PLA2R IgG4/IgG比值在原发性膜性肾病预后评估中的价值[J]. 检验医学, 2023, 38(12): 1115-1120.
[3]	刘庆阳, 袁建明, 夏进军, 姜风英, 王秋波, 王晓明. 基于GEO数据库和临床样本验证CXCL9作为类风湿关节炎生物标志物的研究[J]. 检验医学, 2023, 38(12): 1121-1129.
[4]	杨晓, 李恩灵, 吴丽霞, 戴颖欣, 王之青, 黄昊, 郑冰. 胞质型抗核抗体对间接免疫荧光法检测抗中性粒细胞胞质抗体的影响[J]. 检验医学, 2023, 38(12): 1135-1140.
[5]	项瑾, 刘爱平, 胡尧, 吴之源, 曹国君, 关明. 新型冠状病毒肺炎患者抗核抗体谱分析和血清加热灭活对检测的影响[J]. 检验医学, 2023, 38(12): 1141-1146.
[6]	成宇, 徐臻, 陆柳, 丁梦蕾, 虞珊珊, 宗明, 范列英. 新型冠状病毒肺炎患者血清抗ACE-2抗体表达及其影响因素分析[J]. 检验医学, 2023, 38(12): 1147-1152.
[7]	游延军, 张欢, 向乾银, 曹长春, 王健, 曾红, 魏元敏, 吴斌, 黄敬双, 季纯宇, 代苗, 秦枫. 原发性膜性肾病标志物抗PLA2R抗体检测方法比较[J]. 检验医学, 2023, 38(12): 1153-1156.
[8]	王丽, 陈琳, 黄卓春. 易误判的ANA荧光模型1例报道[J]. 检验医学, 2023, 38(12): 1157-1159.
[9]	王洪玲, 刘梦娜, 白萍, 廖焕金. AML患者异基因造血干细胞移植后复发危险因素分析[J]. 检验医学, 2023, 38(12): 1160-1166.
[10]	杨茜岚, 汪金玉, 刘舒予, 占伊扬, 刘菁, 贾坚. 南京市鼓楼社区老年人群高脂血症与内皮细胞微粒的相关性[J]. 检验医学, 2023, 38(12): 1167-1172.
[11]	代芳芳, 鲁辛辛, 于艳华, 陈铭, 孙桂珍. HIV/AIDS患者分枝杆菌检出情况分析[J]. 检验医学, 2023, 38(12): 1173-1176.
[12]	顾玉, 梁晓艳, 马胜辉, 佟娜, 程明艳, 阎泽君. 血浆生物标志物在慢性肾脏病伴血栓栓塞患者中的表达及其近期预后评估价值[J]. 检验医学, 2023, 38(12): 1177-1182.
[13]	周维, 诸佩超, 宋颖, 缪颖波, 赵强, 徐翀. 抗Xa因子活性室间质量评价调查品制备及应用[J]. 检验医学, 2023, 38(12): 1183-1185.
[14]	努荣古丽·买买提, 衡燕, 张凯迪, 王新玲, 李慧, 杜丹阳, 董玲玲, 郭艳英. 乌鲁木齐地区成年男性骨代谢指标与代谢综合征的相关性分析[J]. 检验医学, 2023, 38(12): 1186-1190.
[15]	李文静, 陆书华, 李晓哲, 戈宁宁, 董海新. 非O1/非O139群霍乱弧菌血流感染病原学和临床特征[J]. 检验医学, 2023, 38(12): 1191-1194.